Leabaneng Tawe
Leabaneng Tawe has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Andrew P. Steenhoff
Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Global Health Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA
1 shared publication Coleen K. Cunningham
Department of Pediatrics, University of California
1 shared publication- David M. Murdoch
Department of Medicine, Duke University, Durham, NC
1 shared publication - Giacomo Maria Paganotti
Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania
1 shared publication - Isaac Kweku Quaye
Department of Biochemistry, University of Namibia School of Medicine, Windhoek, Namibia
1 shared publication - Ishmael Kasvosve
School of Allied Health Professions University of Botswana Gaborone Botswana
1 shared publication
Latest Publications
- Open Access
- 9 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Mapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control
Background and Aim: Cervical cancer is a major public health issue in Botswana, driven by high HIV prevalence and limited screening access. Molecular detection of high‐risk human papillomavirus (hrHPV) is crucial for prevention and early diagnosis. The aim of this narrative review is to synthesize studies evaluating seven HPV detection platforms used in Botswana, focusing on diagnostic performance, feasibility, and scalability. Methods: A comprehensive literature search was conducted across PubMed, PMC, Google Scholar, and regional repositories up to July 2025 to identify studies evaluating HPV detection platforms in Botswana. Eligible studies included those assessing molecular HPV assays or genotyping tools in Botswana populations, reporting diagnostic performance or feasibility data. Data extracted covered study population characteristics, sample types, detection platforms, hrHPV prevalence, and performance metrics. Findings were qualitatively synthesized to compare platforms by sample type and application, as heterogeneity precluded meta‐analysis. Results: The Cepheid Xpert HPV assay, with near‐point‐of‐care capability, self‐sampling suitability, and high sensitivity (96%) and specificity (90%), is well‐suited for national programs despite costs of $15–$25 per test. AmpFire, costing $10–$15 per test, requires minimal equipment, offers good field feasibility (92% sensitivity, 88% specificity), and is promising for community deployment. Laboratory‐based assays like Roche Linear Array and Abbott RealTime deliver broader genotyping and > 93% sensitivity but require centralized infrastructure. PathoChip microarray detects novel HPV types yet is cost‐prohibitive (> $150/test). Double‐nested PCR aids retrospective formalin‐fixed paraffin‐embedded (FFPE) analysis but lacks practicality. These platforms collectively enhance cervical cancer prevention strategies in Botswana. Conclusions: This review identifies feasible HPV detection platforms for Botswana's cervical cancer control. Cepheid Xpert and AmpFire assays offer accurate, affordable, and field‐ready options for early diagnosis and wider screening access. Integrating these molecular tools into existing HIV and reproductive health services could enhance prevention, early detection, and progress toward WHO cervical cancer elimination goals.
- 9 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessMapping the HPV Detection Landscape in Botswana: A Narrative Review of Diagnostic Platforms and Their Impact on Cervical Cancer Control
Background and Aim: Cervical cancer is a major public health issue in Botswana, driven by high HIV prevalence and limited screening access. Molecular detection of high‐risk human papillomavirus (hrHPV) is crucial for prevention and early diagnosis. The aim of this narrative review is to synthesize studies evaluating seven HPV detection platforms used in Botswana, focusing on diagnostic performance, feasibility, and scalability. Methods: A comprehensive literature search was conducted across PubMed, PMC, Google Scholar, and regional repositories up to July 2025 to identify studies evaluating HPV detection platforms in Botswana. Eligible studies included those assessing molecular HPV assays or genotyping tools in Botswana populations, reporting diagnostic performance or feasibility data. Data extracted covered study population characteristics, sample types, detection platforms, hrHPV prevalence, and performance metrics. Findings were qualitatively synthesized to compare platforms by sample type and application, as heterogeneity precluded meta‐analysis. Results: The Cepheid Xpert HPV assay, with near‐point‐of‐care capability, self‐sampling suitability, and high sensitivity (96%) and specificity (90%), is well‐suited for national programs despite costs of $15–$25 per test. AmpFire, costing $10–$15 per test, requires minimal equipment, offers good field feasibility (92% sensitivity, 88% specificity), and is promising for community deployment. Laboratory‐based assays like Roche Linear Array and Abbott RealTime deliver broader genotyping and > 93% sensitivity but require centralized infrastructure. PathoChip microarray detects novel HPV types yet is cost‐prohibitive (> $150/test). Double‐nested PCR aids retrospective formalin‐fixed paraffin‐embedded (FFPE) analysis but lacks practicality. These platforms collectively enhance cervical cancer prevention strategies in Botswana. Conclusions: This review identifies feasible HPV detection platforms for Botswana's cervical cancer control. Cepheid Xpert and AmpFire assays offer accurate, affordable, and field‐ready options for early diagnosis and wider screening access. Integrating these molecular tools into existing HIV and reproductive health services could enhance prevention, early detection, and progress toward WHO cervical cancer elimination goals.
- 17 November 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (2) , e32167
Sickle Cell Disease and Hemoglobin S Prevalence in Botswana
Introduction: Sickle cell disease is an autosomal recessive blood disorder due to a mutation in the gene encoding the β‐globin chain. Epidemiological studies suggest that individuals with the sickle traits have protection against severe and uncomplicated Plasmodium falciparum malaria. In Botswana, the frequency of the HbS allele remains unknown. This study aimed to determine the frequency of the HbS allele in the Ngami and Okavango health districts, areas with relatively high malaria incidence. Method: Residual DNA samples previously collected from asymptomatic children during a Malaria Indicator Survey were used for this study, with variant detection conducted via PCR‐restriction fragment length polymorphism analysis. Results: A total of 159 samples were analyzed, 79 from Ngami and 80 from Okavango. The results showed that 98.1% of the study subjects had the wild type (Hb‐AA) alleles, 1.9% carried sickle cell trait (Hb‐AS), and none had homozygous sickle cell (Hb‐SS). The frequency of the S allele was found to be 0.0094. Conclusions: The presence of the S allele in Botswana, albeit at a low frequency, suggests that sickle cell disease can be a potential contributor to chronic hemolytic disorders in Botswana.
- 17 November 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (2) , e32167
Sickle Cell Disease and Hemoglobin S Prevalence in Botswana
Introduction: Sickle cell disease is an autosomal recessive blood disorder due to a mutation in the gene encoding the β‐globin chain. Epidemiological studies suggest that individuals with the sickle traits have protection against severe and uncomplicated Plasmodium falciparum malaria. In Botswana, the frequency of the HbS allele remains unknown. This study aimed to determine the frequency of the HbS allele in the Ngami and Okavango health districts, areas with relatively high malaria incidence. Method: Residual DNA samples previously collected from asymptomatic children during a Malaria Indicator Survey were used for this study, with variant detection conducted via PCR‐restriction fragment length polymorphism analysis. Results: A total of 159 samples were analyzed, 79 from Ngami and 80 from Okavango. The results showed that 98.1% of the study subjects had the wild type (Hb‐AA) alleles, 1.9% carried sickle cell trait (Hb‐AS), and none had homozygous sickle cell (Hb‐SS). The frequency of the S allele was found to be 0.0094. Conclusions: The presence of the S allele in Botswana, albeit at a low frequency, suggests that sickle cell disease can be a potential contributor to chronic hemolytic disorders in Botswana.
- Open Access
Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana
Children living with HIV (CLWH) are at high risk of colonization and infection by bacterial respiratory pathogens, though this risk can be reduced by other microbes in the upper respiratory microbiome. The impact of HIV infection on development of the upper respiratory microbiome during childhood is poorly understood, and we sought to address this knowledge gap by identifying associations between HIV infection and the nasopharyngeal microbiomes of children in Botswana. We enrolled Batswana CLWH (Corynebacterium species associated with respiratory health. These findings suggest that the upper respiratory microbiome may contribute to the high risk of bacterial respiratory infections among CLWH.
Open AccessAlterations of the upper respiratory microbiome among children living with HIV infection in Botswana
Children living with HIV (CLWH) are at high risk of colonization and infection by bacterial respiratory pathogens, though this risk can be reduced by other microbes in the upper respiratory microbiome. The impact of HIV infection on development of the upper respiratory microbiome during childhood is poorly understood, and we sought to address this knowledge gap by identifying associations between HIV infection and the nasopharyngeal microbiomes of children in Botswana. We enrolled Batswana CLWH (Corynebacterium species associated with respiratory health. These findings suggest that the upper respiratory microbiome may contribute to the high risk of bacterial respiratory infections among CLWH.